The transgene is designed with an enhanced green fluorescent protein (EGFP) driven by 5.4kb of the epidermal growth factor-like domain 7 (Egfl7) regulatory sequences (including 2 ETS response elements), and followed by an SV40 polyadenylation sequence. EGFP expression is observed in the allantois, yolk sac, and in the embryo proper. In adults, expression is seen in the uterus, ovary, and in the neovasculature. (J:213414)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count